益生菌 － 黃世豪腸胃及肝臟科專科醫生＠FindDoc.com
FindDoc Facebook : https://www.facebook.com/FindDoc
FindDoc WeChat : 快徳健康香港 FindDoc
FindDoc Instagram：@finddochk
（一）食物補充益生菌可行嗎？ 00:06
（二）益生菌是什麼？ 00:42
（三）益生菌有什麼功用？ 01:23
（四）醫生如何選擇適合病人的益生菌？ 01:54
(本短片作健康教育之用，並不可取代任何醫療診斷或治療。治療成效因人而異，如有疑問，請向專業醫療人士諮詢。)
參考資料：
1. Lisko, D. J., Johnston, G. P., & Johnston, C. G. (2017). Effects of Dietary Yogurt on the Healthy Human Gastrointestinal (GI) Microbiome. Microorganisms, 5(1), 6. https://doi.org/10.3390/microorganisms5010006
2. Kechagia, M., Basoulis, D., Konstantopoulou, S., Dimitriadi, D., Gyftopoulou, K., Skarmoutsou, N., & Fakiri, E. M. (2013). Health benefits of probiotics: a review. ISRN nutrition, 2013, 481651. https://doi.org/10.5402/2013/481651
3. Hill, D., Sugrue, I., Tobin, C., Hill, C., Stanton, C., & Ross, R. P. (2018). The Lactobacillus casei Group: History and Health Related Applications. Frontiers in microbiology, 9, 2107. https://doi.org/10.3389/fmicb.2018.02107
4. Akatsu H., Iwabuchi N., Xiao J., Matsuyama Z., Kurihara R., Okuda K., et al. (2013). Clinical effects of probiotic Bifidobacterium longum BB536 on immune function and intestinal microbiota in elderly patients receiving enteral tube feeding. J. Parenter Enteral Nutr. 37 631–640. 10.1177/0148607112467819
5. Yang, G., Liu, Z. Q., & Yang, P. C. (2013). Treatment of allergic rhinitis with probiotics: an alternative approach. North American journal of medical sciences, 5(8), 465–468. https://doi.org/10.4103/1947-2714.117299
6. Uronis, J. M., Arthur, J. C., Keku, T., Fodor, A., Carroll, I. M., Cruz, M. L., Appleyard, C. B., & Jobin, C. (2011). Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis. Inflammatory bowel diseases, 17(1), 289–297. https://doi.org/10.1002/ibd.21366
7. Fedorak R. N. (2010). Probiotics in the management of ulcerative colitis. Gastroenterology & hepatology, 6(11), 688–690.
8. Dale, H. F., Rasmussen, S. H., Asiller, Ö. Ö., & Lied, G. A. (2019). Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review. Nutrients, 11(9), 2048. https://doi.org/10.3390/nu11092048
9. Mimura, T., Rizzello, F., Helwig, U., Poggioli, G., Schreiber, S., Talbot, I. C., Nicholls, R. J., Gionchetti, P., Campieri, M., & Kamm, M. A. (2004). Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut, 53(1), 108–114. https://doi.org/10.1136/gut.53.1.108
資料來源：https://www.FindDoc.com
查詢醫生資訊：
https://www.finddoc.com
FindDoc Facebook : https://www.facebook.com/FindDoc
FindDoc WeChat : 快徳健康香港 FindDoc
FindDoc Instagram：@finddochk
（一）食物補充益生菌可行嗎？ 00:06
（二）益生菌是什麼？ 00:42
（三）益生菌有什麼功用？ 01:23
（四）醫生如何選擇適合病人的益生菌？ 01:54
(本短片作健康教育之用，並不可取代任何醫療診斷或治療。治療成效因人而異，如有疑問，請向專業醫療人士諮詢。)
參考資料：
1. Lisko, D. J., Johnston, G. P., & Johnston, C. G. (2017). Effects of Dietary Yogurt on the Healthy Human Gastrointestinal (GI) Microbiome. Microorganisms, 5(1), 6. https://doi.org/10.3390/microorganisms5010006
2. Kechagia, M., Basoulis, D., Konstantopoulou, S., Dimitriadi, D., Gyftopoulou, K., Skarmoutsou, N., & Fakiri, E. M. (2013). Health benefits of probiotics: a review. ISRN nutrition, 2013, 481651. https://doi.org/10.5402/2013/481651
3. Hill, D., Sugrue, I., Tobin, C., Hill, C., Stanton, C., & Ross, R. P. (2018). The Lactobacillus casei Group: History and Health Related Applications. Frontiers in microbiology, 9, 2107. https://doi.org/10.3389/fmicb.2018.02107
4. Akatsu H., Iwabuchi N., Xiao J., Matsuyama Z., Kurihara R., Okuda K., et al. (2013). Clinical effects of probiotic Bifidobacterium longum BB536 on immune function and intestinal microbiota in elderly patients receiving enteral tube feeding. J. Parenter Enteral Nutr. 37 631–640. 10.1177/0148607112467819
5. Yang, G., Liu, Z. Q., & Yang, P. C. (2013). Treatment of allergic rhinitis with probiotics: an alternative approach. North American journal of medical sciences, 5(8), 465–468. https://doi.org/10.4103/1947-2714.117299
6. Uronis, J. M., Arthur, J. C., Keku, T., Fodor, A., Carroll, I. M., Cruz, M. L., Appleyard, C. B., & Jobin, C. (2011). Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis. Inflammatory bowel diseases, 17(1), 289–297. https://doi.org/10.1002/ibd.21366
7. Fedorak R. N. (2010). Probiotics in the management of ulcerative colitis. Gastroenterology & hepatology, 6(11), 688–690.
8. Dale, H. F., Rasmussen, S. H., Asiller, Ö. Ö., & Lied, G. A. (2019). Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review. Nutrients, 11(9), 2048. https://doi.org/10.3390/nu11092048
9. Mimura, T., Rizzello, F., Helwig, U., Poggioli, G., Schreiber, S., Talbot, I. C., Nicholls, R. J., Gionchetti, P., Campieri, M., & Kamm, M. A. (2004). Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut, 53(1), 108–114. https://doi.org/10.1136/gut.53.1.108
資料來源：https://www.FindDoc.com
查詢醫生資訊：
https://www.finddoc.com
